UMRX Insider Trading Activity and SEC Form 4 Filings
UMRX insider trading summary
No open-market insider purchases or sales of Unum Therapeutics Inc. (UMRX) have been reported on SEC Form 4 in the past 12 months.
Latest UMRX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Aug 18, 2020 | Bong Y Koh | 10% Owner | Buy | $265K (101,000 @ $2.62) |
| Aug 18, 2020 | VHCP Co-Investment Holdings III, LLC | 10% Owner | Buy | $265K (101,000 @ $2.62) |
| Aug 18, 2020 | VHCP Management II, LLC | 10% Owner | Buy | $265K (101,000 @ $2.62) |
| Aug 18, 2020 | VHCP Management III, LLC | 10% Owner | Buy | $265K (101,000 @ $2.62) |
| Aug 18, 2020 | Nimish P Shah | 10% Owner | Buy | $265K (101,000 @ $2.62) |
| Aug 18, 2020 | Venrock Healthcare Capital Partners II, L.P. | 10% Owner | Buy | $265K (101,000 @ $2.62) |
| Aug 18, 2020 | Venrock Healthcare Capital Partners III, L.P. | 10% Owner | Buy | $265K (101,000 @ $2.62) |
| Aug 18, 2020 | VHCP Co-Investment Holdings II, LLC | 10% Owner | Buy | $265K (101,000 @ $2.62) |
| Aug 17, 2020 | VHCP Management II, LLC | 10% Owner | Buy | $643K (250,000 @ $2.57) |
| Aug 17, 2020 | Nimish P Shah | 10% Owner | Buy | $643K (250,000 @ $2.57) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.